Nasdaq · Healthcare
Lifeward Ltd. (LFWD)
As-reported financials and recent SEC filings for Lifeward Ltd., latest fiscal period FY2025. Every figure is pulled straight from the company’s EDGAR filings — no estimates.
Snapshot
Revenue
$22.0M
Net income
$-19.9M
Net margin
-90.4%
Diluted EPS
$-17.16
ROE
-236.8%
P/E (TTM)
—
Market cap
—
Debt / equity
—
Income statement (as reported)
| Line | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | $22.0M | $25.7M | $13.9M | $5.5M | $6.0M |
| Gross profit | $8.4M | $8.2M | $4.5M | $1.9M | $2.9M |
| Operating income | $-19.7M | $-29.3M | $-23.6M | $-19.1M | $-12.7M |
| Net income | $-19.9M | $-28.9M | $-22.1M | $-19.6M | $-12.7M |
| Diluted EPS | $-17.16 | $-39.96 | $-31.13 | $-28.60 | $-17.55 |
Source: company XBRL financial statements on SEC EDGAR.
Recent SEC filings
SD2026-05-29
View on EDGAR →S-82026-05-20
View on EDGAR →10-Q2026-05-20
View on EDGAR →42026-05-20
View on EDGAR →32026-05-20
View on EDGAR →8-K2026-05-19
View on EDGAR →NT 10-Q2026-05-15
View on EDGAR →8-K2026-05-15
View on EDGAR →Largest Healthcare peers
Go deeper on LFWD
Search Lifeward Ltd.’s filings with cited answers, compare it against peers, build an operating model, and track it in your portfolio — all in one place.
Start freeOr check your whole portfolio free — no account needed.
Data sourced from SEC EDGAR (public domain). Figures are as-reported and may be unaudited or restated; verify against the source filing before relying on them. Informational only — not investment advice.